Home
Guro Kristin Melve's picture

Guro Kristin Melve

  • E-mailGuro.Melve@uib.no
  • Phone+47 55 97 24 72
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Melve, Guro Kristin; Ersvær, Elisabeth; Rye, Kristin Paulsen; Ahmed, Aymen B; Kristoffersen, Einar Klæboe; Hervig, Tor; Reikvam, Håkon; Hatfield, Kimberley Joanne; Bruserud, Øystein. 2018. The healthy donor profile of immunoregulatory soluble mediators is altered by stem cell mobilization and apheresis. Cytotherapy. 740-754.
  • Melve, Guro Kristin; Ersvær, Elisabeth; Eide, Geir Egil; Kristoffersen, Einar Klæboe; Bruserud, Øystein. 2018. Peripheral blood stem cell mobilization in healthy Donors by granulocyte colony-stimulating factor causes preferential mobilization of lymphocyte subsets. Frontiers in Immunology. 1-15.
  • Tvedt, Tor Henrik Anderson; Melve, Guro Kristin; Tsykunova, Galina; Ahmed, Aymen B; Brenner, Annette; Bruserud, Øystein. 2018. Immunological heterogeneity of healthy peripheral blood stem cell donors - Effects of granulocyte colony-stimulating factor on inflammatory responses. International Journal of Molecular Sciences. 1-16.
  • Hatfield, Kimberley Joanne; Melve, Guro Kristin; Bruserud, Øystein. 2017. Granulocyte colony-stimulating factor alters the systemic metabolomic profile in healthy donors. Metabolomics. 1-10.
  • Melve, Guro Kristin; Ersvær, Elisabeth; Akkøk, Cigdem Ahaein; Ahmed, Aymen B; Kristoffersen, Einar Klæboe; Hervig, Tor; Bruserud, Øystein. 2016. Immunomodulation induced by stem cell mobilization and harvesting in healthy donors: Increased systemic osteopontin levels after treatment with granulocyte colony-stimulating factor. International Journal of Molecular Sciences.
  • Reikvam, Håkon; Kittang, Astrid Marta Olsnes; Melve, Guro Kristin; Mosevoll, Knut Anders; Bentsen, Pål Tore; Ersvær, Elisabeth; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2013. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions? Current Cancer Drug Targets. 30-47.
  • Mosevoll, Knut Anders; Akkøk, Cigdem Ahaein; Hervig, Tor; Melve, Guro Kristin; Bruserud, Øystein; Reikvam, Håkon. 2013. Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 850-860.
  • Bruserud, Øystein; Liseth, Knut; Stamnesfet, Siren; Cacic, Daniel Limi; Melve, Guro Kristin; Kristoffersen, Einar Klæboe; Hervig, Tor; Reikvam, Håkon. 2013. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. Transfusion Medicine. 397-406.
  • Reikvam, Håkon; Mosevoll, Knut Anders; Melve, Guro Kristin; Günther, Clara-Cecilie; Sjo, Malvin; Bentsen, Pål Tore; Bruserud, Øystein. 2012. The pretransplantation serum cytokine profile in allogeneic stem cell recipients differs from healthy individuals, and various profiles are associated with different risks of posttransplantation complications. Biology of Blood and Marrow Transplantation. 190-199.
  • Akkæk, Cigdem Ahaein; Liseth, Knut; Melve, Guro Kristin; Ersvær, Elisabeth; Hervig, Tor; Bruserud, Øystein. 2011. Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts? Cytotherapy. 1013-1024.
  • Ersvær, Elisabeth; Melve, Guro Kristin; Bruserud, Øystein. 2011. Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation? Cancer Immunology and Immunotherapy. 1669-1681.
  • Akkæk, Cigdem Ahaein; Hervig, Tor; Stamnesfet, Siren; Nesthus, Ingerid; Melve, Guro Kristin; Lassalle, Philippe; Bruserud, Øystein. 2011. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 1259-1268.
  • Melve, Guro Kristin; Hervig, Tor; Seghatchian, Jerard. 2010. Self-treatment of an ABO-incompatible blood transfusion. Transfusion and Apheresis Science. 215-216.
  • Melve, Guro Kristin; Myrmel, Helge; Eide, Geir Egil; Hervig, Tor. 2009. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors. Transfusion. 2359-2365.
Editorial
  • Bruserud, Øystein; Melve, Guro Kristin; Gedde-Dahl, Thobias; Tvedt, Tor Henrik Anderson. 2018. Immunological heterogeneity of healthy peripheral blood stem cell donors?preharvesting donor characteristics, additional heterogeneity induced by granulocyte colony-stimulating factor and possible importance for outcome after allotransplantation. Expert Review of Hematology. 1-3.
Abstract
  • Reikvam, Håkon; Melve, Guro Kristin; Svendheim, Kjersti; Hervig, Tor. 2010. Why is potentional blood donors deferred from donation? Haematologica. 738-738.
Academic literature review
  • Melve, Guro Kristin; Ersvær, Elisabeth; Kittang, Astrid Marta Olsnes; Bruserud, Øystein. 2011. The chemokine system. in allogeneic stem-cell transplantation: a possible therapeutic target? 563-576.

More information in national current research information system (CRIStin)